Full text

Turn on search term navigation

© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Kashin–Beck disease (KBD) is a multifactorial endemic disease that only occurs in specific Asian areas. Mycotoxin contamination, especially from the Fusarium spp., has been considered as one of the environmental risk factors that could provoke chondrocyte and cartilage damage. This study aimed to investigate whether new mycotoxins could be identified in KBD-endemic regions as a potential KBD risk factor. This was investigated on 292 barley samples collected in Tibet during 2009–2016 and 19 wheat samples collected in Inner Mongolia in 2006, as control, from KBD-endemic and non-endemic areas. The LC-HRMS(/MS) data, obtained by a general mycotoxin extraction technic, were interpreted by both untargeted metabolomics and molecular networks, allowing us to identify a discriminating compound, enniatin B, a mycotoxin produced by some Fusarium spp. The presence of Fusarium spp. DNA was detected in KBD-endemic area barley samples. Further studies are required to investigate the role of this mycotoxin in KBD development in vivo.

Details

Title
Untargeted Metabolomics Approach Correlated Enniatin B Mycotoxin Presence in Cereals with Kashin–Beck Disease Endemic Regions of China
Author
Sun, Danlei 1 ; Chasseur, Camille 2 ; Mathieu, Françoise 3   VIAFID ORCID Logo  ; Lechanteur, Jessica 4 ; Pierre Van Antwerpen 5   VIAFID ORCID Logo  ; Rasschaert, Joanne 4 ; Fontaine, Véronique 2   VIAFID ORCID Logo  ; Delporte, Cédric 5   VIAFID ORCID Logo 

 Unit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université libre de Bruxelles (ULB), 1050 Brussels, Belgium[email protected] (V.F.); Unit of Pharmacognosy, Bioanalysis and Drug Discovery Unit & Analytical Platform of the Faculty of Pharmacy (APFP), Faculty of Pharmacy, Université libre de Bruxelles (ULB), 1050 Brussels, Belgium; [email protected] 
 Unit of Microbiology, Bioorganic and Macromolecular Chemistry, Faculty of Pharmacy, Université libre de Bruxelles (ULB), 1050 Brussels, Belgium[email protected] (V.F.) 
 Kashin–Beck Disease Fund, 6953 Forrieres, Belgium 
 Laboratory of Bone and Metabolic Biochemistry, Faculty of Medicine, Université libre de Bruxelles (ULB), 1070 Brussels, Belgium; [email protected] (J.L.); [email protected] (J.R.) 
 Unit of Pharmacognosy, Bioanalysis and Drug Discovery Unit & Analytical Platform of the Faculty of Pharmacy (APFP), Faculty of Pharmacy, Université libre de Bruxelles (ULB), 1050 Brussels, Belgium; [email protected] 
First page
533
Publication year
2023
Publication date
2023
Publisher
MDPI AG
e-ISSN
20726651
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2869643242
Copyright
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.